Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-26T04:25:05.472Z Has data issue: false hasContentIssue false
  • English
  • Français

Probing dexfenfluramine

Published online by Cambridge University Press:  02 January 2018

Alan Byrne ,
Feargus O'Croinin  and
Terry Zibin
Alan Byrne
Affiliation:
Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada T6G 2B7
Feargus O'Croinin
Affiliation:
Alberta Hospital Ponoka, Ponoka, Alberta, Canada T0C 2H0
Terry Zibin
Affiliation:
Alberta Hospital Ponoka, Ponoka, Alberta, Canada T0C 2H0
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 161 , Issue 5 , November 1992 , pp. 721
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

References

Ricuarte, G. A., Molliver, M. E., Martello, M. B. (1991) Dexfenfluramine neurotoxicity in brains of non-human primates. Lancet, 338, 1487–1488.CrossRefGoogle Scholar
Rowland, N. E. & Carlton, J. (1986) Neurobiology of an anorectic drug: dexfenfluramine. Progress in Neurobiology, 27, 13–62.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.